"You are my sunshine, my only sunshine": maternal vitamin D status and supplementation in pregnancy and their effect on neonatal and childhood outcomes.
Dimitra VasdekiGeorgios TsamosTheocharis KoufakisDimitrios G GoulisByron AsimakopoulosVassiliki MichouVasileios PatriarcheasKalliopi KotsaPublished in: Hormones (Athens, Greece) (2023)
Vitamin D (VD) plays a crucial role in regulating calcium homeostasis, while the wealth of its pleiotropic actions is gaining increasing research interest. Sufficient VD concentrations are of clinical relevance, particularly in the context of physiological alterations, such as those occurring during pregnancy when maternal VD is the sole source for the developing fetus. As a result, inadequate VD concentrations in pregnancy have been associated with perinatal complications and adverse neonatal outcomes, including preeclampsia, gestational diabetes mellitus, increased rates of cesarean section, low birth weight, small-for-gestational-age infants, poor immune and skeletal growth, allergies, and respiratory infections. Over the past few decades, several observational studies have underlined the important role of maternal VD in the neural, musculoskeletal, and psychomotor growth and bone health of the offspring. However, the complexity of the factors involved in regulating and assessing VD homeostasis, including race, sun exposure, dietary habits, and laboratory measurement techniques, makes the interpretation of relevant research findings challenging. The aim of this narrative review is to summarize the evidence on the importance of VD in maintaining optimal health during pregnancy, infancy, childhood, and adolescence.
Keyphrases
- pregnancy outcomes
- preterm birth
- birth weight
- gestational age
- low birth weight
- pregnant women
- public health
- healthcare
- weight gain
- preterm infants
- mental health
- health information
- risk factors
- body mass index
- adipose tissue
- metabolic syndrome
- skeletal muscle
- body composition
- health promotion
- early life
- young adults
- social media
- electronic health record
- adverse drug